ResMed Fiscal Q1 Adjusted Earnings, Revenue Rise

04:28 PM EDT, 10/29/2026 (MT Newswires) -- ResMed (RMD) reported fiscal Q1 adjusted earnings late Thursday of $2.91 per diluted share, up from $2.55 a year earlier. Analysts polled by FactSet expected $2.69. Revenue in the three months ended Sept. 30 rose to $1.42 billion from $1.34 billion a year earlier. Analysts projected $1.39 billion. The company expects fiscal 2027 non-GAAP EPS of $12 to $12.25 on revenue of $5.75 billion to $5.85 billion. Analysts project EPS of $12.18 on revenue of $5.81 billion.